CompletedNot Applicable

Controlled Terminal Reperfusion With Cold Preservation Solution in the cDCD III Donor

Italy20 participantsStarted 2025-03-17

Plain-language summary

The goal of this observational study is to describe the details of a controlled administration strategy of cold preservation solution or oxygenated cold preservation solution at the end of Abdominal Normothermic Regional Perfusion (A-NRP) in Controlled Donation afeter Circulatory determination of Death (cDCD) III donors. The main purpose is to: develope a standardized protocol for this type of donor Data collected from partecipants, deceased donors belonging to cDCD III category, willl be analysed through descriptive stastistics.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Deceased donor screened for death according to category III cardiovascular criteria, according to the modified Maastricht classification, procured and subjected to Abdominal Normothermic Regional Perfusion (A-NRP); * Donor risk assessment as standard or negligible/acceptable non-standard risk, according to the nomenclature and guidelines of the National Transplant Center (risk definition is established by the CRT-ER, possibly after consulting with the national second opinion) Exclusion Criteria: * Presence of absolute contraindications to organ donation; * Dissent to donation expressed during life; * Opposition by eligible family members unless specifically expressing their wishes; * Unacceptable risk according to the National Transplant Center (CNT) guidelines; * Lack of authorization from the Prosecutor's Office in cases where required; * Infeasibility of the controlled administration of cold preservation solution with or without oxygenation, in the judgment of the first operator and/or the perfusionist in charge.

What they're measuring

Speed of administration of the preservation solution (mL/min)

Timeframe: the expected duration of the study is 1 year and 3 months: one year will be dedicated to the prospective enrollement of category III cDCD donors and the collection of the retrospective data, 3 months to the processing and analysis of the study data.

Time required for administration of the preservation solution (h and min)

Occurence and type of mechanical complications (involving the extracorporeal circuit or the perfusion system in use) during controleld adminsitration of the preservation solution

Inability to perform reperfusion through the extracorporeal circuit and specific reasons

Timeframe: The expected duration of the study is 1 year and 3 months: one year will be dedicated to the prospective enrollement of category III cDCD donors and the collection of the retrospective data, 3 months to the processing and analysis of the study data.

Trial details

NCT IDNCT07421726

SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-16

View on ClinicalTrials.gov More Transplant Patients trials